We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of KN026 Combined With KN046 in Patients With Locally Advanced HER2-positive Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04521179
Recruitment Status : Active, not recruiting
First Posted : August 20, 2020
Last Update Posted : May 23, 2022
Peking University
Information provided by (Responsible Party):
Jiangsu Alphamab Biopharmaceuticals Co., Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : October 1, 2022
Estimated Study Completion Date : October 1, 2023